Mr. McGahan brings more than two decades of executive leadership experience across the healthcare, pharmaceutical, and life sciences sectors, with a distinguished track record in corporate governance, compliance, and regulatory strategy. He most recently served as Executive Vice President, Chief Legal Officer, and Corporate Secretary at Spectrum Pharmaceuticals (NASDAQ: SPPI), where he guided the company through significant corporate milestones, culminating in its successful acquisition in 2023.

Earlier in his career, Mr. McGahan held senior legal and compliance positions at Avanir Pharmaceuticals and Johnson & Johnson, where he led global compliance initiatives and provided strategic legal oversight for innovative therapeutic portfolios. He also served in the U.S. Navy healthcare system as General Counsel and Chief Compliance Officer at the Naval Hospital Camp Pendleton and as Assistant General Counsel to the Navy Surgeon General.

As Chief Legal Officer, Mr. McGahan will oversee all legal, compliance, and governance functions at Nouveau Biosciences. He will play a key role in shaping the company’s regulatory pathway, strengthening its intellectual property portfolio, and supporting strategic collaborations.